Sympathetic nerve activity after thoracoscopic cardiac resynchronization therapy in congestive heart failure
- PMID: 16198249
- DOI: 10.1016/j.cardfail.2005.04.001
Sympathetic nerve activity after thoracoscopic cardiac resynchronization therapy in congestive heart failure
Abstract
Background: Sympathetic benefits of thoracoscopic cardiac resynchronization therapy (TCRT) in congestive heart failure (CHF) are unknown. We determined cardiac hemodynamics, functional status, and muscle sympathetic nerve activity (MSNA) in a group of TCRT patients. We aimed to compare these patients with CHF patients with cardiac asynchrony (ASY) to substantiate the beneficial effects of TCRT.
Methods and results: Eleven patients resynchronized by TCRT 6 +/- 1 months before study inclusion (SYN) and 10 matched ASY patients underwent blood pressure, heart rate, and MSNA recordings. All underwent functional status, cardiac index, and left ventricular ejection fraction (LVEF) assessments. SYN patients had shorter QRS duration and interventricular mechanical delays, longer 6 minute walking distance and lower New York Heart Association class (all P < .05) than ASY patients. MSNA of 56 +/- 2 bursts/min in ASY patients was higher than in SYN patients (48 +/- 3 bursts/min, P < .05). Cardiac index was higher in SYN patients than in ASY patients (2.8 +/- 0.2 versus 1.9 +/- 0.2 L.min.m2, P < .05, respectively). MSNA was highest in the patients with the lowest LVEF (r = -0.49, P < .05), cardiac index (r = -0.48, P < .05) and 6-minute walking distance (r = -0.50, P < .05).
Conclusion: Lower sympathetic nerve activities in TCRT patients are related to more favorable cardiac indexes and six minute walking distances suggesting a sympathetic, hemodynamic, and functional improvement by TCRT.
Similar articles
-
Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.Ital Heart J. 2004 May;5(5):364-70. Ital Heart J. 2004. PMID: 15185900
-
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report.J Hypertens. 2017 Dec;35(12):2532-2536. doi: 10.1097/HJH.0000000000001498. J Hypertens. 2017. PMID: 28816745 Free PMC article.
-
Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.J Med Assoc Thai. 2007 Jul;90(7):1458-66. J Med Assoc Thai. 2007. PMID: 17710992
-
[Selection of patients for resynchronization therapy. "The role of echocardiography"].Arch Cardiol Mex. 2007 Apr-Jun;77 Suppl 2:S2-14-S2-23. Arch Cardiol Mex. 2007. PMID: 17972372 Review. Spanish.
-
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis.J Hypertens. 2019 Sep;37(9):1746-1756. doi: 10.1097/HJH.0000000000002093. J Hypertens. 2019. PMID: 30950979
Cited by
-
Acute electromyostimulation decreases muscle sympathetic nerve activity in patients with advanced chronic heart failure (EMSICA Study).PLoS One. 2013 Nov 12;8(11):e79438. doi: 10.1371/journal.pone.0079438. eCollection 2013. PLoS One. 2013. PMID: 24265770 Free PMC article. Clinical Trial.
-
Sympathetic vasoconstrictor activity before and after left ventricular assist device implantation in patients with end-stage heart failure.Eur J Heart Fail. 2021 Nov;23(11):1955-1959. doi: 10.1002/ejhf.2344. Epub 2021 Oct 5. Eur J Heart Fail. 2021. PMID: 34496114 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous